BrainStorm Cell Therapeutics
BCLI
#10402
Rank
$6.62 M
Marketcap
$0.60
Share price
0.00%
Change (1 day)
-62.03%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -$11.45 Million USD

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$11.63 Million USD, an increase over its 2023 earnings that were of -$17.2 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$11.45 Million-1.51%
2024 -$11.63 Million-32.39%
2023 -$17.2 Million-29.18%
2022 -$24.28 Million-0.74%
2021 -$24.46 Million-23.12%
2020 -$31.82 Million36.8%
2019 -$23.26 Million66.71%
2018 -$13.95 Million181.66%
2017 -$4.96 Million-0.6%
2016 -$4.99 Million-41.31%
2015 -$8.49 Million-8.22%
2014 -$9.25 Million89.74%
2013 -$4.88 Million42.27%
2012 -$3.43 Million-12.45%
2011 -$3.92 Million63.04%
2010 -$2.4 Million35.52%
2009 -$1.78 Million-48.99%
2008 -$3.48 Million-44.39%
2007 -$6.25 Million
2005 -$3.24 Million-91.44%
2004 -$37.78 Million94007.62%
2003 -$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
$9.88 B-86,455.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-$0.76 Billion 6,468.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-$0.8 Billion 6,805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.90 B-16,731.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$20.66 M-280.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-$0.26 Billion 2,131.73%๐Ÿ‡บ๐Ÿ‡ธ USA